iMcKesson, the e-health business launched with much fanfare by McKesson/HBOC less than a year ago, has met with a swift end. McKesson/HBOC plans to fold the unit’s physician and transaction processing services into its information technologies
iMcKesson, the e-health business launched with much fanfare by McKesson/HBOC less than a year ago, has met with a swift end. McKesson/HBOC plans to fold the unit’s physician and transaction processing services into its information technologies division and drop the iMcKesson name. The company attributes the sudden restructuring to changes in market conditions. iMcKesson CEO David Mahoney, who was also co-CEO of McKesson/HBOC, plans to leave the company. John Hammergren, chair of the board, is now president and CEO of McKesson/HBOC. iMcKesson lost $124 million in the first nine months of the current fiscal year, although $95 million of that was attributed to write-offs on investments such as WebMD.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.